PortfoliosLab logoPortfoliosLab logo
FULC vs. TRTN-PA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FULC vs. TRTN-PA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulcrum Therapeutics, Inc. (FULC) and Triton International Ltd (TRTN-PA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FULC achieves a -65.96% return, which is significantly lower than TRTN-PA's 3.89% return.


FULC

1D
2.12%
1M
-41.40%
YTD
-65.96%
6M
-67.35%
1Y
-46.30%
3Y*
7.03%
5Y*
-15.20%
10Y*

TRTN-PA

1D
0.02%
1M
0.07%
YTD
3.89%
6M
5.11%
1Y
10.12%
3Y*
8.88%
5Y*
6.49%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FULC vs. TRTN-PA - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
FULC
Fulcrum Therapeutics, Inc.
-65.96%140.64%-30.37%-7.28%-58.85%51.07%-29.63%14.76%
TRTN-PA
Triton International Ltd
3.89%9.17%10.10%8.47%-0.37%8.71%7.39%7.67%

Correlation

The correlation between FULC and TRTN-PA is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jul 18, 2019

0.11

Fundamentals

Market Cap

FULC:

$293.43M

TRTN-PA:

$2.58B

EPS

FULC:

-$1.15

TRTN-PA:

$4.65

PB Ratio

FULC:

0.88

TRTN-PA:

1.62

Total Revenue (TTM)

FULC:

$0.00

TRTN-PA:

$1.35B

Gross Profit (TTM)

FULC:

$0.00

TRTN-PA:

$872.64M

EBITDA (TTM)

FULC:

-$78.37M

TRTN-PA:

$1.11B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FULC vs. TRTN-PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FULC
FULC Risk / Return Rank: 2222
Overall Rank
FULC Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
FULC Sortino Ratio Rank: 2929
Sortino Ratio Rank
FULC Omega Ratio Rank: 2929
Omega Ratio Rank
FULC Calmar Ratio Rank: 2121
Calmar Ratio Rank
FULC Martin Ratio Rank: 1010
Martin Ratio Rank

TRTN-PA
TRTN-PA Risk / Return Rank: 8282
Overall Rank
TRTN-PA Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
TRTN-PA Sortino Ratio Rank: 7575
Sortino Ratio Rank
TRTN-PA Omega Ratio Rank: 7676
Omega Ratio Rank
TRTN-PA Calmar Ratio Rank: 8686
Calmar Ratio Rank
TRTN-PA Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FULC vs. TRTN-PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and Triton International Ltd (TRTN-PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FULCTRTN-PADifference
Sharpe ratioReturn per unit of total volatility

-1.84

Sortino ratioReturn per unit of downside risk

-2.02

Omega ratioGain probability vs. loss probability

0.98

1.26

-0.27

Calmar ratioReturn relative to maximum drawdown

-0.59

3.46

-4.05

Martin ratioReturn relative to average drawdown

-1.34

13.06

-14.40

FULC vs. TRTN-PA - Sharpe Ratio Comparison

The current FULC Sharpe Ratio is -0.47, which is lower than the TRTN-PA Sharpe Ratio of 1.37. The chart below compares the historical Sharpe Ratios of FULC and TRTN-PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FULC vs. TRTN-PA - Drawdown Comparison

The maximum FULC drawdown since its inception was -92.70%, which is greater than TRTN-PA's maximum drawdown of -57.11%. Use the drawdown chart below to compare losses from any high point for FULC and TRTN-PA.


Loading charts...

Drawdown Indicators


FULCTRTN-PADifference

Max Drawdown

Largest peak-to-trough decline

-92.70%

-57.11%

-35.59%

Max Drawdown (1Y)

Largest decline over 1 year

-78.49%

-2.93%

-75.56%

Max Drawdown (3Y)

Largest decline over 3 years

-79.08%

-2.94%

-76.14%

Max Drawdown (5Y)

Largest decline over 5 years

-92.70%

-7.48%

-85.22%

Current Drawdown

Current decline from peak

-87.57%

-0.42%

-87.15%

Average Drawdown

Average peak-to-trough decline

-62.83%

-2.31%

-60.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.55%

0.78%

+33.77%

Volatility

FULC vs. TRTN-PA - Volatility Comparison

Fulcrum Therapeutics, Inc. (FULC) has a higher volatility of 74.34% compared to Triton International Ltd (TRTN-PA) at 1.81%. This indicates that FULC's price experiences larger fluctuations and is considered to be riskier than TRTN-PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FULCTRTN-PADifference

Volatility (1M)

Calculated over the trailing 1-month period

74.34%

1.81%

+72.53%

Volatility (6M)

Calculated over the trailing 6-month period

87.06%

5.21%

+81.85%

Volatility (1Y)

Calculated over the trailing 1-year period

99.81%

7.40%

+92.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.35%

8.80%

+102.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.66%

21.28%

+90.38%

Dividends

FULC vs. TRTN-PA - Dividend Comparison

FULC has not paid dividends to shareholders, while TRTN-PA's dividend yield for the trailing twelve months is around 8.32%.


PositionTTM2025202420232022202120202019
FULC
Fulcrum Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TRTN-PA
Triton International Ltd
8.32%8.30%8.33%8.45%8.43%7.75%7.81%5.80%

Financials

FULC vs. TRTN-PA - Financials Comparison

This section allows you to compare key financial metrics between Fulcrum Therapeutics, Inc. and Triton International Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M202220232024202520260
331.25M
(FULC) Total Revenue
(TRTN-PA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


FULC and TRTN-PA have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FULC has higher volatility (74.34%) compared to TRTN-PA (1.81%). In terms of maximum drawdown, FULC dropped -92.70% vs TRTN-PA's -57.11%.

TRTN-PA currently has the higher Sharpe Ratio (1.37 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FULC and TRTN-PA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer